A recent study highlighted the considerable upregulation of TRIM59 in recurrent bladder cancer, involving the F-actin/ITGB8/TRIM59/AKT/mTOR/glycolysis pathways [35]. This evidence concerns the gene TRIM59 and urinary bladder carcinoma.